In one paragraphArticle in The Journal of pharmacology and experimental therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
Mayur K LadumorDepartment of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics, Merck & Co., Inc., West Point, Pennsylvania (M.K.L.); Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario (C.A.M.); Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis-Saint Paul, Minnesota (C.D.P.); and Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (F.R., E.R.G.).ORCID https://orcid.org/0000-0003-2632-8525 Catharine A MielnikDepartment of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics, Merck & Co., Inc., West Point, Pennsylvania (M.K.L.); Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario (C.A.M.); Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis-Saint Paul, Minnesota (C.D.P.); and Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (F.R., E.R.G.).ORCID https://orcid.org/0000-0001-8168-1036 Cristina D PetersonDepartment of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics, Merck & Co., Inc., West Point, Pennsylvania (M.K.L.); Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario (C.A.M.); Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis-Saint Paul, Minnesota (C.D.P.); and Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (F.R., E.R.G.).ORCID https://orcid.org/0000-0001-7132-5310 Freeborn RwereDepartment of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics, Merck & Co., Inc., West Point, Pennsylvania (M.K.L.); Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario (C.A.M.); Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis-Saint Paul, Minnesota (C.D.P.); and Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (F.R., E.R.G.).ORCID https://orcid.org/0000-0002-7037-6850 Eric R GrossDepartment of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics, Merck & Co., Inc., West Point, Pennsylvania (M.K.L.); Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario (C.A.M.); Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis-Saint Paul, Minnesota (C.D.P.); and Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (F.R., E.R.G.) ergross@stanford.edu.ORCID https://orcid.org/0000-0002-0589-6446 Funding
Precision Targeting of Aldehyde Pathways for Patients Requiring AnesthesiaR35GM119522 · NIGMS · STANFORD UNIVERSITY · PI Eric Richard Gross · 2016 to 2026
$5.1MNIGMS NIH HHS R35 GM119522
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Fellowships and ScholarshipsPeer Review
Identifiers
PMID38637017
PMCPMC11026149
What OpenQuestion holds
Textmetadata
Read underepoch 390